MiRus completed a highly oversubscribed $65 million funding round for growth of its spine and extremity portfolios and development of structural heart disease solutions...
MicroPort Scientific Corporation ("MicroPort®") announced that MicroPort Cardiac Rhythm Management Limited ("MicroPort® CRM"), which is MicroPort®'s subsidiary focused on developing and commercializing implantable pacemaker and...
Oversubscribed Lumira Ventures IV to continue successful focus backing biotechnology and medtech companies in Canada and U.S.
Companion strategic fund formed in partnership with international pharmaceutical company
During...
Multimodal healthcare provider Carbon Health has closed a massive $350 million investment round led by Blackstone’s Horizon platform. The new capital brings Carbon Health’s...
Neuspera Medical’s miniaturized neuromodulation device may take up mere millimeters of space, but it’s making an outsized impact on the field of medical technology.
The...
Santa Clara, CA-based Ancora Heart is developing the AccuCinch System, a device-therapy designed to improve the structure and function of the heart and help...
- Seventure Partners and Novartis Pharmaceuticals join as new investors- Transformative treatment for millions of children with myopia
Dopavision, a company pioneering the development of...
Imperative Care announced that it closed a $260 million Series D financing round to support its stroke care technologies.
Campbell, Calif.-based Imperative Care had its funding...
